Mitochondrial metabolism plays an
essential role in various biological
processes of cancer cells. Herein, we established an experimental
procedure for the metabolic assessment of mitochondria in cancer cells.
We examined procedures for mitochondrial isolation coupled with various
mitochondrial extraction buffers in three major cancer cell lines
(PANC1, A549, and MDA-MB-231) and identified a potentially optimal
and generalized approach. The purity of the mitochondrial fraction
isolated by the selected protocol was verified using specific protein
markers of cellular components, and the ultrastructure of the isolated
mitochondria was also analyzed by transmission electron microscopy.
The isolation procedure, involving a bead beater for cell lysis, a
modified sucrose buffer, and differential centrifugation, appeared
to be a suitable method for the extraction of mitochondria from cancer
cells. Electron micrographs indicated an intact two-layer membrane
and inner structures of mitochondria isolated by this procedure. Metabolomic
and lipidomic analyses were conducted to examine the metabolic phenotypes
of the mitochondria-enriched fractions and associated bulk cancer
cells. A total of 44 metabolites, including malate and succinate,
occurred at significantly higher levels in the mitochondrial fractions,
whereas 51 metabolites, including citrate, oxaloacetate, and fumarate
of the Krebs cycle and the oncometabolites glutamine and glutamate,
were reduced in mitochondria compared to that in the corresponding
bulk cells of PANC1. Similar patterns were observed in mitochondria
and bulk cells of MDA-MB-231 and A549 cell lines. A clear difference
between the lipid profiles of bulk PANC1, MDA-MB-231, and A549 and
corresponding mitochondrial fractions of these cell lines was detected
by principal component analysis. In conclusion, we developed an experimental
procedure for a large-scale metabolic assessment for suborganelle
metabolic profiling and multiple omics data integration in cancer
cells with broad applications.